Literature DB >> 2164464

Trichosanthin in the treatment of hydatidiform mole. Clinical analysis of 52 cases.

P X Lu1, Y C Jin.   

Abstract

During 1972-1986, 44 of 52 patients (84.6%) with hydatidiform mole were treated successfully with trichosanthin. Of these, 38 (73.1%) had complete spontaneous evacuation and 6 (11.5%) incomplete evacuation. The average time for evacuation of hydatidiform mole was 4.5 +/- 1.64 days. The amount of bleeding was less than 100 ml in 33 patients (75%), while that in 2 of the patients with incomplete evacuation was more than 300 ml. Malignant changes occurred in two of the 44 patients (4.5%). The malignant rate was similar to that (4-12.5, P greater than 0.05) of prophylactic chemotherapy. We consider that thrichosanthin is a better approach to the treatment of hydatidiform mole.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2164464

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  3 in total

1.  Effect of extracts of trichosanthes root tubers on HepA-H cells and HeLa cells.

Authors:  Chang-Ming Dou; Ji-Cheng Li
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

2.  Induced apoptotic action of recombinant trichosanthin in human stomach adenocarcinoma MCG803 cells.

Authors:  Jun Xu; De-Fu Gao; Guo-Li Yan; Jian-Ming Fan
Journal:  Mol Biol Rep       Date:  2008-09-05       Impact factor: 2.316

3.  Trichosanthin, an initiator of the alternative complement activation pathway.

Authors:  X Chen; B L Ma
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.